X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4348) 4348
Publication (210) 210
Book Review (84) 84
Book Chapter (77) 77
Conference Proceeding (12) 12
Book / eBook (6) 6
Magazine Article (4) 4
Web Resource (4) 4
Paper (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3766) 3766
female (2470) 2470
thrombophilia (1837) 1837
index medicus (1649) 1649
male (1616) 1616
adult (1490) 1490
hematology (1418) 1418
risk factors (1290) 1290
middle aged (1198) 1198
thrombosis (1048) 1048
anticoagulants - therapeutic use (1010) 1010
peripheral vascular disease (1007) 1007
pregnancy (979) 979
thrombophilia - complications (936) 936
thrombophilia - drug therapy (899) 899
thrombophilia - etiology (800) 800
aged (775) 775
thrombophilia - genetics (701) 701
venous thromboembolism (694) 694
factor-v-leiden (606) 606
risk (594) 594
thrombophilia - diagnosis (591) 591
thromboembolism (551) 551
mutation (537) 537
thrombophilia - blood (528) 528
venous thrombosis (513) 513
adolescent (485) 485
factor v - genetics (429) 429
deep-vein thrombosis (409) 409
activated protein-c (391) 391
treatment outcome (378) 378
anticoagulants (375) 375
venous thrombosis - etiology (372) 372
risk-factors (356) 356
recurrence (350) 350
retrospective studies (329) 329
anticoagulants - administration & dosage (319) 319
child (308) 308
medicine, general & internal (306) 306
molecular-weight heparin (306) 306
prospective studies (306) 306
women (305) 305
inherited thrombophilia (298) 298
thrombophilia - epidemiology (295) 295
thrombosis - etiology (294) 294
obstetrics & gynecology (280) 280
aged, 80 and over (279) 279
prevalence (279) 279
therapy (277) 277
young adult (277) 277
prothrombin - genetics (270) 270
heparin, low-molecular-weight - therapeutic use (267) 267
coagulation (260) 260
anticoagulants - adverse effects (257) 257
case-control studies (257) 257
disease (248) 248
venous thrombosis - drug therapy (242) 242
heparin (230) 230
thrombophilia - therapy (230) 230
fibrinolytic agents - therapeutic use (222) 222
surgery (218) 218
follow-up studies (213) 213
anticoagulation (205) 205
diagnosis (204) 204
incidence (204) 204
infant, newborn (203) 203
antiphospholipid syndrome (202) 202
prevention (201) 201
heparin - therapeutic use (200) 200
pulmonary-embolism (200) 200
venous thrombosis - diagnosis (197) 197
stroke (193) 193
care and treatment (192) 192
genetic predisposition to disease (192) 192
pregnancy complications, hematologic - drug therapy (189) 189
warfarin - therapeutic use (189) 189
management (188) 188
venous thrombosis - epidemiology (187) 187
antiphospholipid antibodies (185) 185
pregnancy outcome (185) 185
cardiac & cardiovascular systems (183) 183
thromboembolism - etiology (182) 182
pediatrics (180) 180
abridged index medicus (179) 179
pulmonary embolism (174) 174
animals (173) 173
child, preschool (172) 172
thrombosis - prevention & control (169) 169
complications (167) 167
factor v leiden (166) 166
risk assessment (166) 166
prognosis (163) 163
cancer (162) 162
health aspects (160) 160
time factors (160) 160
resistance (159) 159
aspirin - therapeutic use (158) 158
blood coagulation tests (156) 156
children (155) 155
platelet aggregation inhibitors - therapeutic use (153) 153
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3848) 3848
Spanish (149) 149
French (130) 130
German (117) 117
Russian (66) 66
Italian (27) 27
Japanese (19) 19
Polish (17) 17
Czech (16) 16
Bulgarian (14) 14
Croatian (7) 7
Portuguese (6) 6
Chinese (4) 4
Danish (4) 4
Hungarian (4) 4
Dutch (3) 3
Swedish (3) 3
Turkish (3) 3
Hebrew (2) 2
Serbian (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Stroke, ISSN 0039-2499, 01/2011, Volume 42, Issue 1, pp. 227 - 276
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of... 
AHA scientific statements | Stroke | Stroke prevention | Transient ischemic attack | Ischemia | ACTIVATED PROTEIN-C | PATENT FORAMEN OVALE | transient ischemic attack | DENSITY-LIPOPROTEIN-CHOLESTEROL | LEFT-VENTRICULAR THROMBI | stroke | CLINICAL NEUROLOGY | AHA Scientific Statements | ischemia | FACTOR-V-LEIDEN | CLINICAL-CARDIOLOGY-SUBCOMMITTEE | SICKLE-CELL-ANEMIA | BODY-MASS INDEX | PERIPHERAL VASCULAR DISEASE | stroke prevention | INTERNAL CAROTID-ARTERY | INDEPENDENT RISK-FACTOR | Recurrence | Thrombophilia - therapy | Ischemic Attack, Transient - therapy | Embolism - therapy | Thrombosis - complications | Humans | Hyperhomocysteinemia - therapy | Male | Thrombophilia - complications | Ischemic Attack, Transient - complications | Atherosclerosis - therapy | Heart Diseases - complications | Cerebral Hemorrhage - therapy | Female | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Platelet Aggregation Inhibitors - adverse effects | Pregnancy Complications, Cardiovascular - therapy | Stroke - prevention & control | Foramen Ovale, Patent - therapy | Embolism - complications | Anemia, Sickle Cell - complications | Risk Factors | Anticoagulants - therapeutic use | Atherosclerosis - complications | Anticoagulants - adverse effects | Evidence-Based Medicine | Pregnancy | Anemia, Sickle Cell - therapy | Stroke - etiology | Heart Diseases - therapy | Foramen Ovale, Patent - complications | Cerebral Hemorrhage - complications | Hyperhomocysteinemia - complications
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 05/2018, Volume 103, Issue 5, pp. 1715 - 1744
Objective: To update the "Testosterone Therapy in Men With Androgen Deficiency Syndromes" guideline published in 2010. Participants: The participants include... 
PROSTATE-SPECIFIC ANTIGEN | URINARY-TRACT SYMPTOMS | HIV-INFECTED MEN | ENDOCRINOLOGY & METABOLISM | PLACEBO-CONTROLLED TRIALS | FAT-FREE MASS | OLDER MEN | RANDOMIZED CONTROLLED-TRIAL | ANDROGEN-DEFICIENT MEN | HEALTHY-YOUNG MEN | HORMONE BINDING GLOBULIN | Blood Chemical Analysis - methods | Endocrinology - trends | Hypogonadism - drug therapy | Diagnostic Techniques, Endocrine - standards | Endocrinology - methods | Hormone Replacement Therapy - standards | Humans | Middle Aged | Male | Evidence-Based Medicine | Blood Chemical Analysis - standards | Consensus | Endocrinology - standards | Aging - blood | Societies, Medical - organization & administration | Aged, 80 and over | Testosterone - deficiency | Hormone Replacement Therapy - methods | Aged | Hypogonadism - diagnosis | Testosterone - blood | Societies, Medical - standards | Hypogonadism - blood | Testosterone - therapeutic use | Myocardial infarction | Heart | Therapy | Prostate-specific antigen | Hematocrit | Medical services | Morning | Sex | Urinary tract | Sleep disorders | Apnea | Fertility | Diagnosis | Heart diseases | Equilibrium dialysis | Monitoring | Formulations | Evaluation | Cerebral infarction | Antigens | Task forces | Stroke | Fasting | Decision making | Committees | Health risks | Pharmacology | Breast cancer | Minority & ethnic groups | Patients | Hypogonadism | Thrombophilia | Testosterone | Androgens | Side effects | Sleep | Globulins | Men | Infarction | Dialysis | Hormone replacement therapy | Diagnostic systems | Clinical medicine | Pharmacokinetics | Prostate cancer | Prostate | Cancer
Journal Article